PLUS vs MLAB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

PLUS

58.1
AI Score
VS
PLUS Wins

MLAB

35.5
AI Score

Investment Advisor Scores

PLUS

58score
Recommendation
HOLD

MLAB

36score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric PLUS MLAB Winner
Forward P/E 17.1527 34.4828 PLUS
PEG Ratio 1.0714 0 Tie
Revenue Growth 1.0% 1.0% Tie
Earnings Growth -28.0% -42.4% PLUS
Tradestie Score 58.1/100 35.5/100 PLUS
Profit Margin 4.9% 1.9% PLUS
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY PLUS

Relative Price Performance (Last 90 Days)

PLUS 1M: +7.0% · 3M: +12.1% MLAB 1M: +1.5% · 3M: +29.2%

Current Technical Phase

PLUS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.5% over 20 days), RSI 61

RSI (14): 60.9 · Price: $93.40

MLAB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.3% over 20 days), RSI 59

RSI (14): 59.2 · Price: $132.55

Fundamentals Snapshot

Metric PLUS MLAB
Market Cap — —
Forward P/E 16.8 24.6
Trailing P/E 19.9 153.9
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.3% 0.6%
Operating Margin 0.1% 0.1%
EPS 4.66 0.84
Dividend Yield 0.01% 0.00%

Frequently Asked Questions

Based on our detailed analysis, PLUS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.